Venture Round - Advicenne

Venture Round - Advicenne

Investment Firm

Overview

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

Announced Date

Mar 20, 2017

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

IRDI

IRDI

IRDI is a early_stage_venture and late_stage_venture and seed firm.

Cemag Invest

Cemag Invest

No designation

Participant Investors

4

Investor Name
Participant InvestorCemag Invest
Participant InvestorInnoBio Fund
Participant InvestorIXO Private Equity
Participant InvestorIRDI

Round Details and Background

Advicenne raised $17179197 on 2017-03-20 in Venture Round

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 05, 2022
Post-IPO Debt - Advicenne
1-5.2M
Aug 11, 2020
Post-IPO Debt - Advicenne
1-7.5M
Oct 27, 2020
Post-IPO Debt - Advicenne
2-5.1M
Mar 20, 2017
Venture Round - Advicenne
5-17.2M

Recent Activity

There is no recent news or activity for this profile.